Management team

Gary also serves as an Operating Partner at Advent International, one of the largest global private equity investment firms, with over 400 investments in more than 40 countries. Prior to BioDuro and Advent International, Gary served as the Senior Vice President of General Mills and the President of General Mills Greater China, where he oversaw strategies across supply chain, marketing, branding and human resources. Gary graduated from Rutgers University with a Bachelor of Science (BS) and Peking University with a Master of Business Administration (MBA).

• BS, Rutgers University and MBA, Peking University
• 30+ years of industry experience
• Background: General Mills, Bristol Myers Squibb

Throughout his career, Armin has held senior leadership positions at well-known organizations such as Thermo Fisher Scientific, WuXi NEXTCODE, CareDx and Ion Torrent. Armin also serves in an advisory capacity at SeromYx Systems among the Board of Directors, and at K2X as an investments advisor. Early in his career, Armin helped to grow two startup companies, Ingenuity Systems (acquired by Qiagen) and ForteBio (now part of Danaher). Armin studied biochemistry in Germany and received his Doctor of Philosophy (PhD) in molecular biology from Brown University.

• Ph.D., Brown University
• 20+ years of industry experience
• Background: Crown Bioscience, Thermo Fisher Scientific

Her HR experience extends from esteemed organizations, including Danaher, Roche, Sanofi, and Carestream Health. Hua graduated from Harbin Institute of Technology with a bachelor’s degree.

• BA, Harbin Institute of Technology
• 20+ years of industry experience
• Background: Danaher, Roche

With extensive experience in cadre training and team building, he has developed enabling courses for senior, mid-level and grassroots teams. Xiang is dedicated to enhancing organizational productivity, efficiency and core competitiveness through lean management and systems development, continuously improving team outputs and profits. Xiang is a graduate of Tianjin University, holding a bachelor’s degree in fine chemical engineering and a master’s degree in organic chemistry

• .MS, Tianjin University
• 10+ years of industry experience
• Background: WuXi AppTec

Prior to BioDuro, Kevin led global marketing and public relations teams across the US and China for the WuXi Chemistry division at WuXi AppTec, and led global marketing efforts for the Oral Dose, Rx and OTC Softgel Business Units at Catalent Pharma Solutions. Earlier in his career, Kevin held marketing roles at ConvaTec and Becton, Dickinson and Company (BD) in addition to scientist roles at Pfizer (Hospira) and AbbVie. Kevin studied chemistry at Northwestern University and business administration at Duke University.

• MBA, Duke University
• 15+ years of industry experience
• Background: Catalent, WuXi AppTec

Most recently, she served as Vice President of R&D Business Development at Curia, where she led global business development initiatives across drug discovery, development, and manufacturing services, successfully building strategic partnerships, and driving significant revenue growth. Throughout her career, Susan has held leadership roles managing complex portfolios across multiple regions, leading high-performing teams. Susan holds an M.S. in Organic Chemistry from The Ohio State University.

• M.S., The Ohio State University
• 20+ years of commercial & scientific experience in life sciences
• Background: AMRI/Curia, Scynexis

Throughout his career, Subas has published over 80 articles, patent applications and book chapters with an emphasis on medicinal and organic chemistries. Prior to BioDuro, Subas worked in medicinal chemistry at Pfizer and Wyeth, where he led research across multiple therapeutic areas. While at Pfizer, he also established partnerships with several leading CROs in Europe and gained a comprehensive understanding of CRO industry operations. Subas holds a PhD in organic chemistry from Purdue University.

• PhD, Purdue University
• ~30 years of industry experience
• Background: Pfizer, Wyeth

Prior to BioDuro, he was the CFO of Frontage Holdings Corporate, a CRO listed in the Hong Kong Stock Exchange. Prior to that, Andrew held C-level finance positions and board membership at multinational companies such as Frontida BioPharm, a CDMO in the US, and Sky Solar Holdings, a NASDAQ listed company. Andrew received his bachelor’s degree in accounting from the University of Shanghai for Science and Technology and an MBA from Washington University in St. Louis.

• MBA, Washington University in St. Louis
• 10+ years of industry experience
• Background: Frontage, Frontida

He brings over 25 years of pharmaceutical industry experience from roles at leading organizations including AstraZeneca and Hengrui Pharmaceuticals, with expertise spanning DMPK, bioanalysis, and preclinical safety assessment across small molecules, peptides, ADCs, PROTACs, and other novel modalities. He has contributed to the evaluation of numerous preclinical candidates and led studies enabling multiple IND filing, with several programs advancing to approved drugs. He has authored and co-authored over 50 publications in peer-reviewed journals. In addition, He is Editorial Boards of ADMET/DMPK; Expert Opinion on Drug Metabolism & Toxicology, and the Co-Chair of 9th IAPC International Meeting: Emerging Technologies in Drug Discovery and Development, 2024, Sept 23-25 Shanghai.

• Stockholm University: Ph.D, Analytical Chemistry
• 25+ years of industry experience
• Background: AstraZeneca, Hengrui Pharmaceuticals

Hao brings over 20 years of senior scientific and operational leadership experience in the life science and pharmaceutical services industry. He has a proven track record of establishing comprehensive discovery chemistry service platforms, building and leading high-performing teams, fostering strong multidisciplinary collaborations, and developing client-focused operational strategies that drive success. He played a critical role in advancing numerous drug discovery programs to the preclinical candidate stage, implementing operational excellence initiatives, and establishing completed lab safety and data integrity compliance systems. Hao holds a PhD in Chemistry from East China University of Science and Technology.

• Ph.D., East China University of Science and Technology
• 20+ years of industry experience
• Background: ChemExplorer, ChemPartner, XtalPi

Before joining BioDuro, Todd led North America business development activities at biopharma technology companies, including Axxam and Evotec (formerly BioFocus), where he established multi-year contracts with industry, academic and government clients. Todd graduated from the University of Connecticut with a bachelor’s degree in chemistry.

• BS, University of Connecticut
• 20+ years of industry experience
• Background: Evotec, Axxam

With more than 20 years of experience in the life sciences industry, he has established and expanded strategic partnerships with leading pharma and biotechnology companies, supporting programs spanning drug discovery, development, and manufacturing. Prior to joining BioDuro, Jafar held positions of increasing responsibility at Aragen (formerly GVK BIO), progressing from laboratory scientist and project management roles to senior business development leadership across European and Asia-Pacific markets. Throughout his career, he has built a strong track record of helping biopharma organizations accelerate innovation through integrated R&D and outsourcing partnerships. Jafar holds a Master’s degree in Organic Chemistry from Vellore Institute of Technology (VIT), India.

• M.S. in Organic Chemistry, Vellore Institute of Technology (VIT), India
• 20+ years of experience in the life sciences industry
• Background: Aragen (formerly GVK BIO)

Earlier in his career, Fred held a business development position at the Development Center for Biotechnology (DCB), providing CRO services to biotechnology and biopharmaceutical companies in the APAC region. Fred graduated with a bachelor’s degree from the University of New South Wales.

• BS, University of New South Wales
• 10+ years of industry experience
• Background: Development Center for Biotechnology (DCB)

Prior to BioDuro, Lin spent 10 years working on new drug discovery programs, especially first-in-class ones, at Novartis and Johnson & Johnson, where she led research across multiple therapeutic areas. Lin studied cell biology, received bachelor’s degree from Peking University and Doctor of Philosophy (PhD) from Chinese Academy of Sciences, respectively.

• PhD, Chinese Academy of Sciences
• 15+ years of industry experience
• Background: Novartis, Johnson & Johnson

Prior to BioDuro, Jack held senior sales positions at WuXi AppTec and Simcere. Jack graduated with a master’s degree from the Ocean University of China.

• MS, Ocean University of China
• 10+ years of industry experience
• Background: WuXi AppTec, Simcere

He received his chemistry education at the Universities of Robert Gordon, St Andrews and Cambridge and executive business development training at IMD Lausanne and London Business School. During his career, he has published more than 100 patents, peer-reviewed journals, and books, with his most notable Roche success being his team’s invention and development of Evrysdi for the treatment of spinal muscular atrophy

During his career at Abbott and AbbVie, he advanced multiple drug discovery programs into clinical development and contributed to the development of Zotarolimus and other therapeutic innovations. Dr. Djuric has authored more than 180 scientific publications and patents and serves on several scientific and editorial advisory boards.